Amy Quinlan is Vice President of Finance of Vor Biopharma Inc.. Currently has a direct ownership of 50,861 shares of VOR, which is worth approximately $45,774. The most recent transaction as insider was on Sep 03, 2024, when has been sold 4,402 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $3,653. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.9K
n/a 3M change
n/a 12M change
Total Value Held $45,774

Amy Quinlan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Payment of exercise price or tax liability
$3,653 $0.83 p/Share
4,402 Reduced 7.97%
50,861 Common Stock
Aug 06 2024
SELL
Payment of exercise price or tax liability
$179 $0.87 p/Share
206 Reduced 0.37%
55,263 Common Stock
Aug 01 2024
SELL
Payment of exercise price or tax liability
$322 $0.94 p/Share
343 Reduced 0.61%
55,469 Common Stock
AQ

Amy Quinlan

Vice President of Finance
Cambridge, MA

Track Institutional and Insider Activities on VOR

Follow Vor Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

News

Receive news related to Vor Biopharma Inc.

Track Activities on VOR